FDA Inspection 775234 - Damien Sanderlin, MD - March 29, 2012

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Record Details

This FDA Inspection record concerns Damien Sanderlin, MD, with an inspection on March 29, 2012, issued by the Center for Biologics Evaluation and Research, covering biologics.

Company: Damien Sanderlin, MD
Inspection Date: March 29, 2012
Product Type: Biologics
Office: Center for Biologics Evaluation and Research

Open in Dashboard

ID · b6ee764f-53bb-4b09-935f-ca1c0faf0102

Violation Codes1

21 CFR 812.100

Full citation text and observation details available on the Dashboard.